Cannara Biotech Company Insiders
Cannara Biotech employs about 11 people. The company is managed by 11 executives with a total tenure of roughly 26 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Recap of Cannara Biotech's management performance can provide insight into the venture performance.
Cannara |
Cannara Biotech Management Team Effectiveness
The company has return on total asset (ROA) of 0.0655 % which means that it generated a profit of $0.0655 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1544 %, meaning that it generated $0.1544 on every $100 dollars invested by stockholders. Cannara Biotech's management efficiency ratios could be used to measure how well Cannara Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Cannara Biotech Workforce Comparison
Cannara Biotech is rated third overall in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 617. Cannara Biotech claims roughly 11.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22. Cannara Biotech Notable Stakeholders
A Cannara Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cannara Biotech often face trade-offs trying to please all of them. Cannara Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cannara Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David Abitbol | Vice Marketing | Profile | |
| France Landry | Vice Resources | Profile | |
| Zohar Krivorot | CEO Chairman | Profile | |
| Avi Krivorot | Chief Officer | Profile | |
| Scott Carroll | Vice Marketing | Profile | |
| Anthony Manouk | VP GM | Profile | |
| Brian Sherman | General Affairs | Profile | |
| Julia Bouvet | Chief Staff | Profile | |
| Etienne Ledoux | Executive Officer | Profile | |
| Nick Dam | Vice Sales | Profile | |
| Alexander Wolfe | VP Devel | Profile |
Cannara Biotech Workforce Analysis
Traditionally, organizations such as Cannara Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cannara Biotech within its industry.Cannara Biotech Manpower Efficiency
Return on Cannara Biotech Manpower
| Revenue Per Employee | 7.4M | |
| Revenue Per Executive | 7.4M | |
| Net Income Per Employee | 585.3K | |
| Net Income Per Executive | 585.3K | |
| Working Capital Per Employee | 3.7M | |
| Working Capital Per Executive | 3.7M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Tools for Cannara Stock
When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |